pcsk9 inhibition: lowering lipids and reducing cardiovascular events
Published 5 years ago • 3.2K plays • Length 1:05:30Download video MP4
Download video MP3
Similar videos
-
26:59
optimizing ldl-c lowering with pcsk9 inhibition
-
3:40
osler trials suggest pcsk9 inhibitor reduces cardiovascular events long term
-
2:31
what are pcsk9 inhibitors? (new lipid lowering drugs)
-
52:04
a real world approach to ldl cholesterol using pcsk9 inhibitors, october 5 2018
-
23:18
professor kausik ray - pcsk9 inhibition – have we reached the limits of lipid lowering and outcome?
-
17:08
lipids series-pcs k9 inhibitors
-
3:41
cost-effectiveness of pcsk9 inhibitors for heterozygous fh or ascvd
-
5:01
cardiac_cpr2 lect _pcsk9 inhibitors (staudinger)
-
58:49
pushing the envelope with pcsk9-twenty years of progress
-
1:37:52
novel therapeutic strategies targeting pcsk9 for reducing ldl-c in hyperlipidemia and ascvd
-
1:03:46
pcsk9 inhibitors within the targeted treatment approach to hypercholesterolemia 4/26/16
-
6:02
pcsk9 inhibitors and cv risk
-
58:08
the cholesterol wars: identifying patients who would most benefit from pcsk9 inhibitors (part 1)
-
1:17
pcsk9 and lp(a), a novel approach to a cv risk factor | professor henry ginsberg
-
5:03
are pcsk9 inhibitors for ldl cholesterol safe and effective?
-
26:44
dr erin bohula may - 'at the limits of lipid management – statins to pcsk9 inhibitors'
-
5:18
lipid management utilizing pcsk9 inhibitors
-
3:50
what is pcsk9 inhibitor?
-
5:38
does pcsk9 inhibition impact atherosclerosis? | professor steve nicholls